0001209191-15-083871.txt : 20151208 0001209191-15-083871.hdr.sgml : 20151208 20151208094123 ACCESSION NUMBER: 0001209191-15-083871 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151204 FILED AS OF DATE: 20151208 DATE AS OF CHANGE: 20151208 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: JUNIPER PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000821995 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 592758596 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4 LIBERTY SQUARE STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 617-639-1500 MAIL ADDRESS: STREET 1: 4 LIBERTY SQUARE STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: COLUMBIA LABORATORIES INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MERRIFIELD C ANN CENTRAL INDEX KEY: 0001247224 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10352 FILM NUMBER: 151274184 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-12-04 0 0000821995 JUNIPER PHARMACEUTICALS INC JNP 0001247224 MERRIFIELD C ANN C/O JUNIPER PHARMACEUTICALS, INC. FOUR LIBERTY SQUARE 4TH FLOOR BOSTON MA 02109 1 0 0 0 common stock, par value $0.01 2015-12-04 4 P 0 1600 12.138 A 7129 D This transaction was executed in a single trade at a price of $12.138. The price reported reflects the weighted-average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range described above. /s/George O. Elston, Attorney-in-Fact 2015-12-08